[go: up one dir, main page]

AU2001267404A1 - Novel compounds for the treatment of inflammatory and cardiovascular diseases - Google Patents

Novel compounds for the treatment of inflammatory and cardiovascular diseases

Info

Publication number
AU2001267404A1
AU2001267404A1 AU2001267404A AU6740401A AU2001267404A1 AU 2001267404 A1 AU2001267404 A1 AU 2001267404A1 AU 2001267404 A AU2001267404 A AU 2001267404A AU 6740401 A AU6740401 A AU 6740401A AU 2001267404 A1 AU2001267404 A1 AU 2001267404A1
Authority
AU
Australia
Prior art keywords
inflammatory
treatment
novel compounds
cardiovascular diseases
cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267404A
Inventor
Helmut Drexler
Wolf-Georg Forssmann
Bernhard Schieffer
Boris Schmidt
Michael Walden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPF Pharmaceuticals GmbH
Original Assignee
IPF Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPF Pharmaceuticals GmbH filed Critical IPF Pharmaceuticals GmbH
Publication of AU2001267404A1 publication Critical patent/AU2001267404A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001267404A 2000-05-04 2001-05-04 Novel compounds for the treatment of inflammatory and cardiovascular diseases Abandoned AU2001267404A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10021615 2000-05-04
DE10021615 2000-05-04
PCT/EP2001/005043 WO2001082858A2 (en) 2000-05-04 2001-05-04 Novel compounds for the treatment of inflammatory and cardiovascular diseases

Publications (1)

Publication Number Publication Date
AU2001267404A1 true AU2001267404A1 (en) 2001-11-12

Family

ID=7640695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267404A Abandoned AU2001267404A1 (en) 2000-05-04 2001-05-04 Novel compounds for the treatment of inflammatory and cardiovascular diseases

Country Status (2)

Country Link
AU (1) AU2001267404A1 (en)
WO (1) WO2001082858A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042443A2 (en) * 2000-11-23 2002-05-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Use of modulators of eukaryotic signal transduction pathways for the treatment of helicobacter infections
EP1356815A4 (en) * 2001-01-29 2007-03-07 Takeda Pharmaceutical PAIN-RELIEF AND ANTI-INFLAMMATORY ACTIVE SUBSTANCES
TWI299663B (en) * 2002-05-14 2008-08-11 Novartis Ag Methods of treatment
US7232828B2 (en) * 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
US7199144B2 (en) 2003-04-21 2007-04-03 Teva Pharmaceuticals Industries, Ltd. Process for the preparation of valsartan and intermediates thereof
DE602004013405T2 (en) 2003-03-17 2009-05-07 Teva Pharmaceutical Industries Ltd. POLYMORPH SHAPES OF VALSARTAN
EP1950204A1 (en) 2003-03-17 2008-07-30 Teva Pharmaceutical Industries Ltd. Amorphous form of valsartan
WO2004094392A1 (en) 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan
EP2321281A4 (en) * 2008-09-02 2011-09-28 Elder Pharmaceuticals Ltd Anti inflammatory compounds
WO2012056294A1 (en) 2010-10-29 2012-05-03 Jubilant Life Sciences Ltd. An improved process for the preparation of n-pentanoyl-n-[[2'-(1h-tetrazol-5-yi)[1,1'-biphenyl]-4-yi]methyl]-l-valine
US12365654B2 (en) 2019-12-02 2025-07-22 Harman Finochem Limited Process for the preparation of highly pure valsartan

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
NZ242724A (en) * 1991-05-15 1994-09-27 Du Pont Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
DE4221009A1 (en) * 1992-06-26 1994-01-05 Bayer Ag Imidazolyl-substituted cyclohexane derivatives

Also Published As

Publication number Publication date
WO2001082858A2 (en) 2001-11-08
WO2001082858A3 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
PL348059A1 (en) Compounds useful in the treatment of inflammatory diseases
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2001233081A1 (en) Composition for treatment of stress
AU2000276362A1 (en) Composition for the treatment of diabetes
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002233928A1 (en) Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AU2001267404A1 (en) Novel compounds for the treatment of inflammatory and cardiovascular diseases
AU2001293891A1 (en) New combination for the treatment of asthma
AU2002309180A1 (en) Composition and kit for the treatment of inflammatory bowel diseases
IL147363A0 (en) Ppar delta inhibitor for the treatment of cardiovascular diseases
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU1405001A (en) Treatment of diseases
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU2001253560A1 (en) Methods of treatment
AU2002240835A1 (en) Process for the manufacture of solid formulations
AU2001262520A1 (en) Combined preparation for the treatment of neoplasic diseases
HK1057754A (en) Compounds useful in the treatment of inflammatory diseases
HK1057753A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases